glutathione mutations in sclc patients Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Differential KEAP1/NRF2 mediated signaling widens
Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Frontiers Therapeutic Potential of Glutamine Pathway in Lung Cancer Oncology Letters glutathione mutations in sclc patients Role of Cancer: From Mechanisms to Therapies Deep Clustering Based Metabolic Stratification of
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



